Trial Profile
A Phase I Trial of Doxil, Bevacizumab and Temsirolimus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Apr 2019
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Doxorubicin liposomal (Primary) ; Temsirolimus (Primary) ; Everolimus; Everolimus
- Indications Cancer
- Focus Adverse reactions
- 09 Apr 2019 Status changed from active, no longer recruiting to completed.
- 17 Sep 2018 Planned End Date changed from 1 Aug 2018 to 1 Aug 2019.
- 17 Sep 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Aug 2019.